関連文献

Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury.

Am J Pathol. 174(4): 1203-1211, 2009.PubMed

Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury.

Am J Pathol. 174(4): 1154-1159, 2009.PubMed

Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.

Shock. 31(5): 454-459, 2009.PubMed

Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury.

Nephron Exp Nephrol. 108(1): e19-26, 2008.PubMed

Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery.

Kidney Int. 73(4): 465-472, 2008.PubMed

Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.

Kidney Int. 73(12): 1374-1384, 2008.PubMed

L-Type Fatty Acid Binding Protein Transgenic Mouse as a Novel Tool to Explore Cytotoxicity to Renal Proximal Tubules.

Drug Metab. Pharmacokinet. 23(4): 271-278, 2008.PubMed

Renal L-type fatty acid-binding protein in acute ischemic injury.

J Am Soc Nephrol. 18(11): 2894-2902, 2007.PubMed

A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure.

Kidney Int. 72(3): 348-358, 2007.PubMed

Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.

Am J Kidney Dis. 47(3): 439-444, 2006.PubMed